acrolein has been researched along with Hypertrophy, Left Ventricular in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bian, ZY; Hu, ZF; Liu, Y; Tang, QZ; Wu, QQ; Yang, L | 1 |
Bhatnagar, A; Chandrasekar, B; Gu, Y; Haberzettl, P; Hamid, T; Ismahil, MA; Prabhu, SD; Srivastava, S | 1 |
2 other study(ies) available for acrolein and Hypertrophy, Left Ventricular
Article | Year |
---|---|
Cinnamaldehyde attenuates pressure overload-induced cardiac hypertrophy.
Topics: Acrolein; Animals; Cytoprotection; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Hemodynamics; Hypertrophy, Left Ventricular; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Protein Kinase Inhibitors; Signal Transduction; Ventricular Function, Left | 2015 |
Chronic oral exposure to the aldehyde pollutant acrolein induces dilated cardiomyopathy.
Topics: Acrolein; Administration, Oral; Animals; Apoptosis; Cardiomyopathy, Dilated; Environmental Pollutants; Gene Expression Regulation; Hypertrophy, Left Ventricular; Immunohistochemistry; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocarditis; Myocardium; Oxidative Stress; Real-Time Polymerase Chain Reaction; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2011 |